Mantell Associates’ Post

Congratulations to our Global Top Performer for June 2024 - Ewan Rennison! Ewan reached an incredible 278% of his monthly target - what an achievement! Huge congratulations and well done, we look forward to your continued success. #topperformer #recruitmentlondon #pharmarecruitment

Eli Lilly and Company is continuing to pursue its newfound passion for radiopharmaceuticals, this time handing Radionetics Oncology $140 million in upfront cash to partner on its pipeline of G protein coupled receptor (GPCR) targeted drugs. Read more below: https://lnkd.in/gnxkk4eE #radiopharma #oncology #pharmanews

LenioBio, a biotech company pioneering cell-free protein production, and Touchlight, a leader in enzymatic DNA production, have entered a supply agreement aimed at leveraging the capabilities of Touchlight’s rapid enzymatic doggybone DNA (dbDNA), to achieve unprecedented speed in vaccine development and manufacture in the context of LenioBio’s CEPI grant. Read more below: https://lnkd.in/ea4jwFRu #therapeutics #biotech #dna

Listen to what our clients and candidates have said about us... A great testimonial for George Hebden Lee, Managing Associate here at MA! "I have worked with Mantell Associates and they offer me help and support in term of career opportunities. They are really trustworthy, honest and professional. I would like to thank George George Hebden‑Lee for his support and advice during the recruitment process. He is a man of integrity and honesty." Contact George Hebden Lee on +44 (0)20 3854 7700. #testimonialtuesday #pharmarecruitment #lifesciencerecruitment

Fortrea has launched a new research and development arm aimed at creating artificial-intelligence-driven clinical trial technologies that make studies speedier, safer and more efficient. Read more below: https://lnkd.in/egQhq44w #clinicaltrials #ai #cro

Seventeen months after SK bioscience introduced its global expansion push—memorably dubbed as “SKBS 3.0”— the Korean developer and manufacturer of vaccines has acquired a 60% stake in IDT Biologika for 339 billion won ($244 million). Read more below: https://lnkd.in/ex4myCSn #acquisition #pharmaexpansion #vaccines

AbbVie is embracing summer’s heat, cranking up the M&A dial with the acquisition of inflammatory disease-focused Celsius Therapeutics for $250 million in cash. Read more below: https://lnkd.in/giwifdHX #acquisition #antibodies #pharmanews

New opportunity! Associate Director of Business Development - Small Molecule - East Coast. Mantell Associates is currently partnered with the CDMO arm of one of the most reputable Life Science organisations on the planet, committed to discovering innovative and vibrant ways to advance global health. You will get the opportunity to work with some of the brightest minds in the industry and join a diverse and inclusive business that offers you limitless career progression. Apply for this role directly - https://lnkd.in/enfyZWUe - or contact Onur Dilek on +44 (0)20 3854 7700. #directorjobs #smallmoleculejobs #bdjobs

David Dwamena discusses strategies for success and offers 10 ways to enhance productivity. Productivity is not just about doing more in less time; it’s about achieving better results with the time and resources available. Read more below: https://lnkd.in/ebYPzpjT #productivity #success #productivetips